A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alberto BOSSI, Doctor
Gustave Roussy, Cancer Campus Grand Paris - Paris
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
77 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Onze Lieve Vrouw Ziekenhuis
Aalst, Belgium
- Hôpitaux Universitaires Bordet Erasme- Institut Jules Bordet
Brussels, Belgium
- Hopital de Jolimont
Haine-Saint-Paul, Belgium
- Az Groeninge Kortrijk - Campus Vercruysselaan
Kortrijk, Belgium
- Cliniques Universitaires Saint-Luc
Leuven, Belgium
- U.Z. Leuven - Campus Gasthuisberg
Leuven, Belgium
- Clinique Claude Bernard
Albi, France
- Institut de Cancerologie de L'Ouest
Angers, France
- Clinique Générale D'Annecy
Annecy, France
- Institut Sainte Catherine
Avignon, France
- Centre de la Baie
Avranches, France
- Centre D'Oncologie Et de Radiothérapie Du Pays Basque
Bayonne, France
- Chu Jean Minjoz
Besançon, France
- Centre Pierre Curie
Beuvry, France
- Institut Bergonie
Bordeaux, France
- Centre François Baclesse
Caen, France
- Centre Hospitalier Alpes Leman
Contamine-sur-Arve, France
- Chu de Mondor
Créteil, France
- Centre Leonard de Vinci
Dechy, France
- Centre Georges-François Leclerc
Dijon, France
- Clinique Sainte Marguerite
Hyères, France
- Chd Vendée
La Roche-sur-Yon, France
- Clinique Victor Hugo
Le Mans, France
- Chu de Limoges
Limoges, France
- Chu Lyon Sud
Lyon, France
- Centre Léon Bérard
Lyon, France
- Chu Timone
Marseille, France
- Hôpital Nord
Marseille, France
- Institut Paoli Calmettes
Marseille, France
- Centre Azuréen de Cancérologie
Mougins, France
- Centre Catherine de Sienne
Nantes, France
- Centre Antoine Lacassagne
Nice, France
- Chu Carémeau
Nîmes, France
- Chr Orléans la Source
Orléans, France
- Hopital Tenon
Paris, France
- Hôpital St Louis
Paris, France
- Institut Curie
Paris, France
- Chic Quimper
Quimper, France
- Institut Jean Godinot
Reims, France
- Centre Eugène Marquis
Rennes, France
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Nov 2013
- Primary completion
- 18 Aug 2021
- Completion
- 31 Dec 2032
- Last update posted
- 12 Nov 2024
- Registered enrollment
- 1,173
- Registry id
- NCT01957436
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.